Verastem Inc.
Organization details
- Legal name
- Verastem Inc.
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 2834 — Pharmaceutical Preparations
- Jurisdiction of incorporation
- Massachusetts
- Headquarters city
- Needham
- Headquarters state / province
- Massachusetts
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- VSTM
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001526119
- EIN
- 27-3269467
Board of directors
-
Anil Kapur · DirectorSince 2023
-
Brian M. Stuglik · Director · Chief Executive OfficerSince 2023
-
Dan Paterson · Director · President and CEOSince 2023
-
Eric K. Rowinsky · DirectorSince 2023
-
John Johnson · DirectorSince 2023
-
Karin Anna Tollefson · DirectorSince 2023
-
Michael Kauffman · Director · President of DevelopmentSince 2023
-
Michael P. Bailey · DirectorSince 2026
-
Michelle Robertson · DirectorSince 2023
-
Paul A. Bunn · DirectorSince 2023
-
Robert E. Gagnon · DirectorSince 2023
Chief executives
Director election results
Annual meeting of May 22, 2025. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
84.3%
-
89.0%
-
98.4%
Board connections
6 of this board's directors also sit on 11 other boards. 10 are in the same sector.
-
Adicet Bio Inc. Same sectorvia Michael Kauffman
-
Axogen Inc. Same sectorvia John Johnson
-
Biogen Inc. Same sectorvia Eric K. Rowinsky
-
Bone Biologics Corp Same sectorvia Robert E. Gagnon
-
Fortress Biotech Inc. Same sectorvia Eric K. Rowinsky
- via Robert E. Gagnon
-
Kyntra Bio Inc. Same sectorvia Michael Kauffman
-
Nurix Therapeutics Inc. Same sectorvia Anil Kapur
-
Puma Biotechnology Inc Same sectorvia Brian M. Stuglik
-
Purple Biotech Ltd. Same sectorvia Robert E. Gagnon
-
Xeris Biopharma Holdings Inc. Same sectorvia John Johnson
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $1,066,161
- 32 sales by 6 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Nov 3, 2026 | Dan Paterson Director, Officer (President and CEO) | Open-market sale | −1,299 | $9.60 | $12,470 |
| Oct 1, 2026 | Calkins Daniel Officer (Chief Financial Officer) | Open-market sale | −2,566 | $8.00 | $20,528 |
| Oct 1, 2026 | Dan Paterson Director, Officer (President and CEO) | Open-market sale | −44,121 | $8.00 | $352,968 |
| Sep 30, 2026 | Calkins Daniel Officer (Chief Financial Officer) | Grant or award | −8,333 | — | — |
| Sep 30, 2026 | Dan Paterson Director, Officer (President and CEO) | Grant or award | −106,893 | — | — |
| Sep 21, 2026 | Calkins Daniel Officer (Chief Financial Officer) | Open-market sale | −55 | $7.70 | $424 |
| Aug 3, 2026 | Dan Paterson Director, Officer (President and CEO) | Open-market sale | −1,302 | $5.81 | $7,565 |
| Jun 22, 2026 | Dan Paterson Director, Officer (President and CEO) | Open-market sale | −20,871 | $4.18 | $87,241 |
| Jun 22, 2026 | Calkins Daniel Officer (Chief Financial Officer) | Open-market sale | −4,032 | $4.18 | $16,854 |
| Jun 22, 2026 | Calkins Daniel Officer (Chief Financial Officer) | Open-market sale | −57 | $4.13 | $235 |
| May 21, 2026 | Michael P. Bailey Director | Grant or award | +108,000 | — | — |
| May 21, 2026 | Karin Anna Tollefson Director | Grant or award | +36,000 | — | — |
| May 21, 2026 | Brian M. Stuglik Director | Grant or award | +36,000 | — | — |
| May 21, 2026 | Eric K. Rowinsky Director | Grant or award | +36,000 | — | — |
| May 21, 2026 | Michelle Robertson Director | Grant or award | +36,000 | — | — |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about Verastem Inc.
Who is the CEO of Verastem Inc.?
Brian M. Stuglik is Verastem Inc.'s Chief Executive Officer.
How many directors are on Verastem Inc.'s board?
Verastem Inc.'s board has 11 directors: Anil Kapur, Brian M. Stuglik, Dan Paterson, Eric K. Rowinsky, John Johnson, Karin Anna Tollefson, Michael Kauffman, Michael P. Bailey, Michelle Robertson, Paul A. Bunn and 1 other.
Are Verastem Inc. insiders buying or selling shares?
Over the last 12 months, Verastem Inc. insiders made no open-market purchases and sold $1.1 million of shares in 32 sales on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="verastem-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.